The role of statins in the management of nonalcoholic fatty liver disease.

CONCLUSION: Since NAFLD/NASH patients have high CVD risk, they will probably require a statin. Thus, why not select a specific statins (atorvastatin or rosuvastatin, both generic now) that offered a substantial liver- and CVD-related adverse event reduction? The administration of statins in these patients is as safe as in the general population.
PMID: 30652643 [PubMed - as supplied by publisher]

Source: Current Pharmaceutical Design - January 16, 2019 Category: Drugs & Pharmacology Authors: Doumas M, Imprialos K, Dimakopoulou A, Stavropoulos K, Binas A, Athyros VG Tags: Curr Pharm Des Source Type: research